INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
SCRI Development Innovations, LLC
SCRI Development Innovations, LLC
Stanford University
Swiss Cancer Institute
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center